Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.04 (-4.84%)
Close on Nov 12, 2026Market cap $45.82MP/E –Yield 0.00%
Pliant Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pliant Therapeutics's profit margin for the twelve months ending Mar 31, 2024 was -68848.0%. For fiscal 2023 it was -10211.1%, against -1273.3% the year before. The highest annual figure on record is -1.1% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -10211.1% | −8937.8 |
| FY2022 | Dec 31, 2022 | -1273.3% | +11.2 |
| FY2021 | Dec 31, 2021 | -1284.5% | −1185.2 |
| FY2020 | Dec 31, 2020 | -99.3% | −98.2 |
| FY2019 | Dec 31, 2019 | -1.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | -16609.7% | −16017.5 |
| Q1 FY2023 | Mar 31, 2023 | -2818.9% | −569.1 |
| Q4 FY2022 | Dec 31, 2022 | -1784.2% | −557.1 |
| Q3 FY2022 | Sep 30, 2022 | -2065.8% | −386.0 |
| Q2 FY2022 | Jun 30, 2022 | -592.2% | +684.0 |
| Q1 FY2022 | Mar 31, 2022 | -2249.8% | −1198.5 |
| Q4 FY2021 | Dec 31, 2021 | -1227.2% | −801.0 |
| Q3 FY2021 | Sep 30, 2021 | -1679.8% | −1336.4 |
| Q2 FY2021 | Jun 30, 2021 | -1276.2% | −803.9 |
| Q1 FY2021 | Mar 31, 2021 | -1051.3% | −1089.4 |
| Q4 FY2020 | Dec 31, 2020 | -426.1% | – |
| Q3 FY2020 | Sep 30, 2020 | -343.5% | – |
| Q2 FY2020 | Jun 30, 2020 | -472.3% | – |
| Q1 FY2020 | Mar 31, 2020 | 38.1% | – |
See a number that looks wrong?